VALIUM CAIRAN INJEKSI 5 MG/ML

국가: 인도네시아

언어: 인도네시아어

출처: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

제품 특성 요약 제품 특성 요약 (SPC)
30-03-2021

유효 성분:

DIAZEPAM

제공처:

BOEHRINGER INGELHEIM INDONESIA - Indonesia

INN (International Name):

DIAZEPAM

복용량:

5 MG/ML

약제 형태:

CAIRAN INJEKSI

패키지 단위:

DUS, 5 AMPUL @ 2 ML

Manufactured by:

CENEXI SAS - France

승인 날짜:

2015-04-08

제품 특성 요약

                                _Draft_Valium_PI_safety-update_CDS9.0_EN_v4_
_ _
_Page 1 of 16_
INFORMATION FOR HEALTH PROFESSIONALS
VALIUM
®
Diazepam
1.
DESCRIPTION
1.1 THERAPEUTIC/PHARMACOLOGIC CLASS OF DRUG
Tranquilizer and anxiolytic.
ATC code: N05BA01.
1.2 TYPE OF DOSAGE FORM
Ampoules.
1.3 ROUTE OF ADMINISTRATION
-
Intravenous injection
-
Intramuscular injection
1.4 STERILE/RADIOACTIVE STATEMENT
Sterile product.
1.5 QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active ingredient:_ diazepam.
Ampoules 10 mg in 2 mL.
Valium ampoules contain benzyl alcohol. For warning related to benzyl
alcohol (see _ 2.4.1 _
_Warnings and Precautions, General_).
2.
CLINICAL
PARTICULARS
2.1 THERAPEUTIC INDICATION(S)
The injection form of Valium is indicated for basal sedation before
proceeding with major
therapeutic interventions, such as cardioversion, cardiac
catheterization, endoscopy, radiological
procedures, minor surgical interventions, in order to relieve
apprehension, anxiety, acute stress
and to diminish recollections of such procedures.
The injection form is also suitable for premedication of patients
suffering from anxiety and stress.
Excitation: In psychiatry, Valium is used in the treatment of
excitation states associated with
acute anxiety and panic, as well as in motor unrest and delirium
tremens.
Valium is indicated to treat status epilepticus and other convulsive
states (including tetanus).
Valium is useful for the relief of reflex muscle spasm due to local
trauma (injury, inflammation).
It
can
also
be
used
to
combat
spasticity
arising
from
damage
to
spinal
and
supraspinal
interneurons e.g. cerebral palsy and paraplegia, as well as in
athetosis and “stiff-man” syndrome.
DISETUJUI OLEH BPOM : 10/03/2021
EREG10036411900296
_Draft_Valium_PI_safety-update_CDS9.0_EN_v4_
_ _
_Page 2 of 16_
2.2 DOSAGE AND ADMINISTRATION
_ _
_GENERAL _
For optimal effect, the dosage should be carefully individualized.
While the usual daily dosages
given below will meet the needs of most patients, there will be some
who may require higher
doses.
For adults and adolesc
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림